magnolol has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, PM; Hsieh, PL; Huang, CC; Liao, YW; Lin, SS; Peng, CY; Yu, CC; Yu, CH | 1 |
1 other study(ies) available for magnolol and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas.
Topics: Biphenyl Compounds; Cell Line, Tumor; Humans; Interleukin-6; Lignans; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor | 2022 |